Ligufalimab and Cadonilimab in Advanced Liver Cancers

Clinical trial NCT06789848 · RECRUITING

Trial details

NCT number: NCT06789848
Sponsor: University of Texas Southwestern Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma Refractory Hepatocellular Carcinoma Biliary Tract Cancer

Start date: 2025-02-18
Primary completion: 2029-05-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.